Chris Callaghan

Has grant

Honorary Reader

King's College London - Guy's Campus

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Chris Callaghan is an Honorary Reader at King's College London - Guy's Campus, UK. His research primarily focuses on kidney transplantation, including acute antibody-mediated rejection, clinical outcomes from deceased donors, and the impact of COVID-19 on solid organ transplant recipients. Recent publications highlight his work on various aspects of organ transplantation, particularly related to infectious diseases and transplantation outcomes in the context of the pandemic.

Recent Grants

Grant: Close

The role of regulatory T cells with indirect specificity for alloantigen in the maintenance of transplant tolerance.

Open Date: 2002-10-01

Close Date: 2005-09-30

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Phillipe Abreu

University of Miami

UNITED STATES

View details

Anthony Dorling

King’s College London

UNITED KINGDOM

View details

Kate Walker

Assistant Professor in Medical Statistics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chris Callaghan

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Modelling acute antibody-mediated rejection of human kidney transplants using ex-vivo warm machine perfusion.

Utilization and clinical outcomes of kidney transplants from deceased donors with albuminuria in the UK: a national cohort study.

Kidney Transplantation From Deceased Donors With Vaccine-induced Immune Thrombocytopenia and Thrombosis: An Updated Analysis of the UK Experience.

Transplantation of Organs From SARS-CoV-2 RNA Positive Deceased Donors: The UK Experience So Far.

Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.

Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients.

Solid Organ Transplantation From Deceased Donors With Infective Endocarditis: The UK Experience.

Time to Improve the Utilization of Kidneys From Donation After Circulatory Death Donors in Pediatric Transplantation.

National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors.

Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016.

Collaborators (3)

Phillipe Abreu

Anthony Dorling

Kate Walker

Make your next move.